Free Trial

Plexus (NASDAQ:PLXS) Upgraded by Wall Street Zen to "Buy" Rating

Plexus logo with Computer and Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Wall Street Zen upgraded Plexus to a "Buy", adding to other analyst upgrades and price-target lifts (Needham to $285) and leaving a street consensus of a "Moderate Buy" with a ~$229.17 target.
  • Plexus beat Q2 expectations, reporting $2.05 EPS vs. $1.87 est. and $1.16B revenue (+18.7% Y/Y), and issued Q3 EPS guidance of 2.020–2.180, helping drive recent share gains.
  • Notable risks include substantial insider selling (50,995 shares in the last 90 days) and a planned CFO retirement, which could create near-term execution and disclosure concerns.
  • MarketBeat previews top five stocks to own in June.

Plexus (NASDAQ:PLXS - Get Free Report) was upgraded by research analysts at Wall Street Zen from a "hold" rating to a "buy" rating in a report issued on Saturday.

PLXS has been the topic of a number of other reports. Raymond James Financial restated an "outperform" rating and issued a $275.00 price target on shares of Plexus in a research note on Thursday. Needham & Company LLC lifted their price target on Plexus from $206.00 to $285.00 and gave the company a "buy" rating in a research note on Friday. Benchmark restated a "buy" rating and issued a $220.00 price target on shares of Plexus in a research note on Monday, March 16th. Weiss Ratings downgraded Plexus from a "buy (b)" rating to a "buy (b-)" rating in a research note on Friday, April 24th. Finally, Williams Trading set a $195.00 price target on Plexus in a research note on Wednesday, January 28th. Five equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $229.17.

Read Our Latest Stock Report on Plexus

Plexus Trading Up 5.6%

NASDAQ:PLXS opened at $264.60 on Friday. The firm has a market cap of $7.09 billion, a P/E ratio of 38.68 and a beta of 0.75. The company has a current ratio of 1.54, a quick ratio of 0.75 and a debt-to-equity ratio of 0.06. The stock's 50 day simple moving average is $211.79 and its 200-day simple moving average is $178.49. Plexus has a 12-month low of $115.35 and a 12-month high of $272.08.

Plexus (NASDAQ:PLXS - Get Free Report) last released its earnings results on Wednesday, April 29th. The technology company reported $2.05 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.87 by $0.18. The business had revenue of $1.16 billion for the quarter, compared to analyst estimates of $1.13 billion. Plexus had a return on equity of 12.84% and a net margin of 4.35%.The company's revenue for the quarter was up 18.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.66 earnings per share. Plexus has set its Q3 2026 guidance at 2.020-2.180 EPS. Equities analysts anticipate that Plexus will post 6.56 EPS for the current year.

Insider Activity at Plexus

In other Plexus news, Director Karen Marie Rapp sold 500 shares of the business's stock in a transaction on Friday, February 27th. The stock was sold at an average price of $195.59, for a total transaction of $97,795.00. Following the sale, the director directly owned 8,535 shares in the company, valued at approximately $1,669,360.65. The trade was a 5.53% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, COO Oliver K. Mihm sold 9,541 shares of the business's stock in a transaction on Wednesday, February 18th. The stock was sold at an average price of $201.40, for a total value of $1,921,557.40. Following the sale, the chief operating officer owned 12,809 shares in the company, valued at approximately $2,579,732.60. The trade was a 42.69% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 50,995 shares of company stock valued at $10,345,971 in the last 90 days. 1.78% of the stock is owned by corporate insiders.

Institutional Trading of Plexus

A number of institutional investors have recently bought and sold shares of the company. Vanguard Group Inc. boosted its position in Plexus by 0.6% during the third quarter. Vanguard Group Inc. now owns 3,683,845 shares of the technology company's stock worth $533,016,000 after purchasing an additional 22,374 shares in the last quarter. Dimensional Fund Advisors LP raised its holdings in shares of Plexus by 0.5% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,373,457 shares of the technology company's stock worth $201,903,000 after acquiring an additional 7,051 shares during the last quarter. American Century Companies Inc. raised its holdings in shares of Plexus by 44.2% in the third quarter. American Century Companies Inc. now owns 1,103,892 shares of the technology company's stock worth $159,722,000 after acquiring an additional 338,119 shares during the last quarter. State Street Corp raised its holdings in shares of Plexus by 2.3% in the second quarter. State Street Corp now owns 1,059,501 shares of the technology company's stock worth $143,361,000 after acquiring an additional 24,115 shares during the last quarter. Finally, BNP PARIBAS ASSET MANAGEMENT Holding S.A. raised its holdings in shares of Plexus by 4.0% in the third quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 915,296 shares of the technology company's stock worth $132,434,000 after acquiring an additional 35,237 shares during the last quarter. 94.45% of the stock is currently owned by hedge funds and other institutional investors.

Key Headlines Impacting Plexus

Here are the key news stories impacting Plexus this week:

  • Positive Sentiment: Q2 results and raised guidance — Plexus reported stronger-than-expected Q2 revenue (about $1.16B, roughly +18.7% Y/Y) and beat headline EPS consensus; management also issued fiscal Q3 guidance above Street estimates (EPS guidance of 2.020–2.180 and revenue guidance above prior consensus), supporting a higher-growth outlook. Earnings Press Release
  • Positive Sentiment: Analyst upgrade / price-target lift — Needham raised its price target to $285 and reaffirmed a Buy, lending institutional support and providing a near-term catalyst for momentum and flows. Benzinga
  • Positive Sentiment: Momentum and ETF interest — Coverage has highlighted Plexus as a momentum play and noted index/ETF buying buzz after the strong quarter, which can amplify upside through passive flows and quant strategies. Kalkine
  • Neutral Sentiment: Analyst consensus / ratings landscape — The street consensus is around a “Moderate Buy” with varied price targets (median near $220); recent upgrades improve sentiment but coverage is limited, so future moves depend on continued execution. American Banking News
  • Neutral Sentiment: Investor materials and call transcripts available — Management provided a slide deck and earnings call transcript that detail program wins and demand drivers; investors should review guidance detail and margin commentary for forward visibility. Earnings Presentation
  • Negative Sentiment: CFO transition announced — CFO Patrick Jermain plans to retire; while Plexus says succession is disciplined, CFO turnover introduces near-term execution and disclosure risk that some investors view negatively. CFO Transition
  • Negative Sentiment: Insider selling and cash-flow notes — Data shows notable insider sales in recent months and some operating cash conversion metrics were weaker y/y; these factors may temper enthusiasm and raise governance/cash-flow questions for value-focused investors. QuiverQuant

Plexus Company Profile

(Get Free Report)

Plexus Corp. NASDAQ: PLXS is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.

Read More

Analyst Recommendations for Plexus (NASDAQ:PLXS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Plexus Right Now?

Before you consider Plexus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Plexus wasn't on the list.

While Plexus currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines